Minimal residual disease detection in acute lymphoblastic leukemia: real improvement with the real-time quantitative PCR method?

J Pediatr Hematol Oncol. 2003 Feb;25(2):100-2. doi: 10.1097/00043426-200302000-00003.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Core Binding Factor Alpha 2 Subunit
  • DNA, Neoplasm / isolation & purification
  • Fusion Proteins, bcr-abl / genetics
  • Homeodomain Proteins / genetics
  • Humans
  • Neoplasm Proteins / genetics*
  • Neoplasm, Residual / diagnosis
  • Oncogene Proteins, Fusion / genetics
  • Polymerase Chain Reaction*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics

Substances

  • Core Binding Factor Alpha 2 Subunit
  • DNA, Neoplasm
  • Homeodomain Proteins
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • TEL-AML1 fusion protein
  • E2A-Pbx1 fusion protein
  • Fusion Proteins, bcr-abl